AI Article Synopsis
- A man with the von Hippel-Lindau (VHL) gene experienced gradual vision loss in his left eye due to a retinal capillary hemangioma (HCR) and cystic edema, alongside bilateral kidney tumors.
- Treatment involved laser photocoagulation, which led to complications including subretinal and vitreous hemorrhage requiring further surgical intervention (vitrectomy).
- Retinal capillary hemangioma is the most common early sign of von Hippel-Lindau disease, necessitating prompt detection and treatment to avoid complications like hemorrhages.
Article Abstract
Clinical Case: Man carrier of the von Hippel-Lindau (VHL) gene, with long-onset loss of vision in left eye. He had a retinal capillary hemangioma (HCR) and diffuse cystic edema in posterior pole. The systemic study revealed bilateral kidney tumors. Laser photocoagulation was performed which produced a subretinal and vitreous hemorrhage that required vitrectomy.
Discussion: Retinal capillary hemangioma (HCR) is the earliest and most frequent manifestation of the von Hippel-Lindau disease. Its detection requires it to be treated early and to rule out other visceral lesions. Laser photocoagulation is the most recommended treatment of small-size HCR. The most frequent complications are vitreous and subretinal haemorrhages.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.oftal.2011.03.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!